FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA)…
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA)…
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
After decades of research, gut microbiome therapies are on the cusp of reaching the market.…
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
French company MaaT Pharma has raised €18M in Series B financing that will support phase…
Lyon is one of the hotspots for biotech in Europe. Here are 10 of the…
The death of a US patient from complications after a fecal transplant last week could…
European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based…
Scientists are uncovering many ways that the microorganisms that share our body can influence our…
A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients…